BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25941919)

  • 41. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.
    Lerman C; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Restine S; Shields PG; Kaufmann V; Redden D; Benowitz N; Berrettini WH
    Pharmacogenomics J; 2004; 4(3):184-92. PubMed ID: 15007373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of the mu opioid receptor gene polymorphism A118G in patients with primary biliary cirrhosis with and without pruritus.
    Wei LX; Floreani A; Variola A; El Younis C; Bergasa NV
    Acta Derm Venereol; 2008; 88(4):323-6. PubMed ID: 18709298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The moderating effect of alcohol-specific parental rule-setting on the relation between the dopamine D2 receptor gene (DRD2), the μ-opioid receptor gene (OPRM1) and alcohol use in young adolescents.
    Pieters S; Van Der Zwaluw CS; Van Der Vorst H; Wiers RW; Smeets H; Lambrichs E; Burk WJ; Engels RC
    Alcohol Alcohol; 2012; 47(6):663-70. PubMed ID: 22798433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alcohol Consumption in Healthy OPRM1 G Allele Carriers and Its Association with Impulsive Behavior.
    Pfeifer P; Sariyar M; Eggermann T; Zerres K; Vernaleken I; Tüscher O; Fehr C
    Alcohol Alcohol; 2015 Jul; 50(4):379-84. PubMed ID: 25836994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects.
    Bach P; Vollsta Dt-Klein S; Kirsch M; Hoffmann S; Jorde A; Frank J; Charlet K; Beck A; Heinz A; Walter H; Sommer WH; Spanagel R; Rietschel M; Kiefer F
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1128-35. PubMed ID: 25937240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.
    Cieślińska A; Sienkiewicz-Szłapka E; Kostyra E; Fiedorowicz E; Snarska J; Wroński K; Tenderenda M; Jarmołowska B; Matysiewicz M
    Tumour Biol; 2015 Jun; 36(6):4655-60. PubMed ID: 25618602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
    Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
    Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.
    Ray LA; Hutchison KE
    Alcohol Clin Exp Res; 2004 Dec; 28(12):1789-95. PubMed ID: 15608594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating.
    Davis CA; Levitan RD; Reid C; Carter JC; Kaplan AS; Patte KA; King N; Curtis C; Kennedy JL
    Obesity (Silver Spring); 2009 Jun; 17(6):1220-5. PubMed ID: 19282821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
    Chu SL; Xiao D; Wang C; Jing H
    Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
    Oertel BG; Doehring A; Roskam B; Kettner M; Hackmann N; Ferreirós N; Schmidt PH; Lötsch J
    Hum Mol Genet; 2012 Nov; 21(21):4751-60. PubMed ID: 22875838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates.
    Barr CS; Schwandt ML; Lindell SG; Higley JD; Maestripieri D; Goldman D; Suomi SJ; Heilig M
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5277-81. PubMed ID: 18378897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)).
    Gelernter J; Kranzler H; Lacobelle J
    Genomics; 1998 Sep; 52(3):289-97. PubMed ID: 9790747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is OPRM1 genotype a valuable predictor of VAS in patients undergoing laparoscopic radical resection of colorectal cancer with fentanyl?
    Zhou Y; Cao L; Yang Y; Gao Y; Li Y; Wang B; Pan B; Huang J; Guo W
    BMC Anesthesiol; 2023 May; 23(1):173. PubMed ID: 37217861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians.
    Iordanidou M; Tavridou A; Petridis I; Kyroglou S; Kaklamanis L; Christakidis D; Manolopoulos VG
    Drug Alcohol Depend; 2010 Apr; 108(1-2):70-6. PubMed ID: 20060656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes.
    Lerer E; Kanyas K; Karni O; Ebstein RP; Lerer B
    Mol Psychiatry; 2006 Aug; 11(8):771-81. PubMed ID: 16770336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia.
    Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY
    Minerva Anestesiol; 2011 Jan; 77(1):33-9. PubMed ID: 21150856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans.
    Lee MR; Gallen CL; Zhang X; Hodgkinson CA; Goldman D; Stein EA; Barr CS
    PLoS One; 2011; 6(9):e24203. PubMed ID: 21912675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
    Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
    J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of the A118G OPRM1 polymorphism with sociotropy and interpersonal sensitivity.
    Suzuki A; Shirata T; Noto K; Matsumoto Y; Muraosa H; Abe M; Goto K; Otani K
    Brain Behav; 2022 Jul; 12(7):e2674. PubMed ID: 35761357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.